# A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031).

> **NCT00267280** · PHASE3 · TERMINATED · sponsor: **Pfizer** · enrollment: 640 (—)

## Conditions studied

- Hyperlipidemia
- Dyslipidemia
- Hypercholesterolemia

## Interventions

- **DRUG:** torcetrapib/atorvastatin
- **DRUG:** simvastatin

## Key facts

- **NCT ID:** NCT00267280
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-01
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 640 (—)
- **Last updated:** 2012-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00267280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00267280, "A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031).". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00267280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*